Digital Transformation Takes Pharma Beyond the Pill

Collaborative deployment of digital enablers such as artificial intelligence, IoT, and blockchain aid in shift toward value-based care Dubai, United Arab Emirates, (AETOSWire)– The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally enabled by the entry of non-traditional tech companies such as Apple, Facebook, and Google—pushing pharmaceutical companies to go beyond-the-pill. However,…

Read More

NovioSense Announces Positive Phase 2 Clinical Trial Results and the Commencement of a Second Follow Up Study

NovioSense has demonstrated the measurement of tear glucose in diabetic patients and the correlation to blood glucose with clinically relevant accuracy. The company announced the commencement of a second, 24-patient study, to validate the use of its tear glucose sensor in type 1 diabetic patients. NIJMEGEN, Netherlands– (BUSINESS WIRE/AETOSWire)– NovioSense BV, the venture capital-backed clinical stage medical device company, today announced positive data from its NLNSGS2017-02 Phase 2 tear glucose sensor study. The NovioSense Glucose Sensor is a device that, when placed in the lower eyelid, continuously measures glucose levels…

Read More